UroGen Pharma Ltd
Biotechnology
Healthcare
URGN
47.42 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
18.13
52 week high
21.42
high
18.22
52 week low
0.00
previous Close
17.99
P/E ratio
market cap
626 M
div yield
0
net profit margin
0.00 %
216.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top